| Symbol |
Name |
|
ACTG2
|
actin, gamma 2, smooth muscle, enteric
|
|
ADORA2A
|
adenosine A2a receptor
|
|
AFP
|
alpha-fetoprotein
|
|
AGO3
|
argonaute RISC catalytic component 3
|
|
AIP
|
aryl hydrocarbon receptor interacting protein
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ANPEP
|
alanyl (membrane) aminopeptidase
|
|
APEX1
|
APEX nuclease (multifunctional DNA repair enzyme) 1
|
|
APOE
|
apolipoprotein E
|
|
CBS
|
cystathionine-beta-synthase
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
|
CD9
|
CD9 molecule
|
|
CDC25A
|
cell division cycle 25A
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CETP
|
cholesteryl ester transfer protein, plasma
|
|
CHRNA3
|
cholinergic receptor, nicotinic, alpha 3 (neuronal)
|
|
CHRNA4
|
cholinergic receptor, nicotinic, alpha 4 (neuronal)
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
COL1A2
|
collagen, type I, alpha 2
|
|
CRTC1
|
CREB regulated transcription coactivator 1
|
|
CRYAB
|
crystallin, alpha B
|
|
CRYGD
|
crystallin, gamma D
|
|
CTAG1B
|
cancer/testis antigen 1B
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYBB
|
cytochrome b-245, beta polypeptide
|
|
CYP11A1
|
cytochrome P450, family 11, subfamily A, polypeptide 1
|
|
DDC
|
dopa decarboxylase (aromatic L-amino acid decarboxylase)
|
|
DDX42
|
DEAD (Asp-Glu-Ala-Asp) box helicase 42
|
|
DHX9
|
DEAH (Asp-Glu-Ala-His) box helicase 9
|
|
DLEU1
|
deleted in lymphocytic leukemia 1 (non-protein coding)
|
|
DLEU2
|
deleted in lymphocytic leukemia 2 (non-protein coding)
|
|
DLG2
|
discs, large homolog 2 (Drosophila)
|
|
DMD
|
dystrophin
|
|
DRD3
|
dopamine receptor D3
|
|
DYNC1I1
|
dynein, cytoplasmic 1, intermediate chain 1
|
|
EPHX2
|
epoxide hydrolase 2, cytoplasmic
|
|
F2
|
coagulation factor II (thrombin)
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
FAS
|
Fas cell surface death receptor
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
|
FGB
|
fibrinogen beta chain
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FMR1
|
fragile X mental retardation 1
|
|
FN1
|
fibronectin 1
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FOSL1
|
FOS-like antigen 1
|
|
FOXP2
|
forkhead box P2
|
|
FUT2
|
fucosyltransferase 2 (secretor status included)
|
|
FUT7
|
fucosyltransferase 7 (alpha (1,3) fucosyltransferase)
|
|
GABRB2
|
gamma-aminobutyric acid (GABA) A receptor, beta 2
|
|
GPLD1
|
glycosylphosphatidylinositol specific phospholipase D1
|
|
HHEX
|
hematopoietically expressed homeobox
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-F
|
major histocompatibility complex, class I, F
|
|
HLTF
|
helicase-like transcription factor
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
|
HNRNPK
|
heterogeneous nuclear ribonucleoprotein K
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HTR1A
|
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled
|
|
IRF3
|
interferon regulatory factor 3
|
|
IRF4
|
interferon regulatory factor 4
|
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)
|
|
ITLN1
|
intelectin 1 (galactofuranose binding)
|
|
JAK2
|
Janus kinase 2
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCNIP3
|
Kv channel interacting protein 3, calsenilin
|
|
KCNQ2
|
potassium channel, voltage gated KQT-like subfamily Q, member 2
|
|
KIFC3
|
kinesin family member C3
|
|
KPNA7
|
karyopherin alpha 7 (importin alpha 8)
|
|
LAMA5
|
laminin, alpha 5
|
|
LILRB1
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1
|
|
MAML2
|
mastermind-like 2 (Drosophila)
|
|
MAVS
|
mitochondrial antiviral signaling protein
|
|
MC4R
|
melanocortin 4 receptor
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MECOM
|
MDS1 and EVI1 complex locus
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MIRLET7A3
|
microRNA let-7a-3
|
|
MMP7
|
matrix metallopeptidase 7
|
|
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1
|
|
MSMB
|
microseminoprotein, beta-
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
MYH11
|
myosin, heavy chain 11, smooth muscle
|
|
MYLIP
|
myosin regulatory light chain interacting protein
|
|
NCOA4
|
nuclear receptor coactivator 4
|
|
NEK2
|
NIMA-related kinase 2
|
|
NOTCH1
|
notch 1
|
|
NOX4
|
NADPH oxidase 4
|
|
NPC1
|
Niemann-Pick disease, type C1
|
|
NPHP4
|
nephronophthisis 4
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
PALB2
|
partner and localizer of BRCA2
|
|
PANK2
|
pantothenate kinase 2
|
|
PAX9
|
paired box 9
|
|
PCOLCE
|
procollagen C-endopeptidase enhancer
|
|
PDCD10
|
programmed cell death 10
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PHOX2A
|
paired-like homeobox 2a
|
|
PIPSL
|
PIP5K1A and PSMD4-like, pseudogene
|
|
PITX2
|
paired-like homeodomain 2
|
|
PLA2G2A
|
phospholipase A2, group IIA (platelets, synovial fluid)
|
|
PLEKHF2
|
pleckstrin homology domain containing, family F (with FYVE domain) member 2
|
|
POU1F1
|
POU class 1 homeobox 1
|
|
PSIP1
|
PC4 and SFRS1 interacting protein 1
|
|
PTCH1
|
patched 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PVRL4
|
poliovirus receptor-related 4
|
|
RAB6C
|
RAB6C, member RAS oncogene family
|
|
REG3G
|
regenerating islet-derived 3 gamma
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RGS4
|
regulator of G-protein signaling 4
|
|
RHAG
|
Rh-associated glycoprotein
|
|
RUNX1
|
runt-related transcription factor 1
|
|
SALL4
|
spalt-like transcription factor 4
|
|
SDHA
|
succinate dehydrogenase complex, subunit A, flavoprotein (Fp)
|
|
SDHB
|
succinate dehydrogenase complex, subunit B, iron sulfur (Ip)
|
|
SENP2
|
SUMO1/sentrin/SMT3 specific peptidase 2
|
|
SERPINI1
|
serpin peptidase inhibitor, clade I (neuroserpin), member 1
|
|
SFN
|
stratifin
|
|
SH3BGRL
|
SH3 domain binding glutamate-rich protein like
|
|
SHH
|
sonic hedgehog
|
|
SLC12A1
|
solute carrier family 12 (sodium/potassium/chloride transporter), member 1
|
|
SLC22A5
|
solute carrier family 22 (organic cation/carnitine transporter), member 5
|
|
SLC44A1
|
solute carrier family 44 (choline transporter), member 1
|
|
SLC6A1
|
solute carrier family 6 (neurotransmitter transporter), member 1
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
|
SLC8A3
|
solute carrier family 8 (sodium/calcium exchanger), member 3
|
|
SLITRK1
|
SLIT and NTRK-like family, member 1
|
|
SPATA16
|
spermatogenesis associated 16
|
|
SULT1E1
|
sulfotransferase family 1E, estrogen-preferring, member 1
|
|
TERF2
|
telomeric repeat binding factor 2
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TH
|
tyrosine hydroxylase
|
|
THRB
|
thyroid hormone receptor, beta
|
|
TLR4
|
toll-like receptor 4
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF11A
|
tumor necrosis factor receptor superfamily, member 11a, NFKB activator
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TP53
|
tumor protein p53
|
|
TXNL1
|
thioredoxin-like 1
|
|
UNG
|
uracil-DNA glycosylase
|
|
USP17L2
|
ubiquitin specific peptidase 17-like family member 2
|
|
USP19
|
ubiquitin specific peptidase 19
|
|
VCX3A
|
variable charge, X-linked 3A
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VPRBP
|
Vpr (HIV-1) binding protein
|
|
VSTM2L
|
V-set and transmembrane domain containing 2 like
|
|
VSX1
|
visual system homeobox 1
|
|
WT1
|
Wilms tumor 1
|
|
YARS2
|
tyrosyl-tRNA synthetase 2, mitochondrial
|
